Esperion Therapeutics, Daiichi Sankyo Europe Ink $125 Mln Amendment To Their Collaboration

Merck, Daiichi Sankyo Say FDA Grants Priority Review In U.S. For Patritumab Deruxtecan

Merck & Co. Inc. (MRK) and Japan's Daiichi Sankyo Co. Ltd. (DSKYF.PK) announced Friday that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the Biologics License Application (BLA) for patritumab deruxtecan (HER3-DXd) for the treatment of adult patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) previously treated with two or more systemic therapies.

RTTNews | 621 dias atrás

Eurozone Private Sector Growth At 1-Year High

The euro area private sector expanded at the fastest pace in a year in August but the overall pace was sluggish as the service sector held back growth, final survey data from S&P Global showed on Wednesday. The HCOB composite output index rose to 51.0 in August from 50.9 in July. The score was slightly below the initial estimate of 51.1.

RTTNews | 1h 8min atrás

Bay Street Likely To Open On Mixed Note

Canadian shares are likely to open on a somewhat mixed note on Wednesday, tracking commodity prices. With some crucial economic data, including jobs data from Canada and the U.S. due later in the week, the mood is likely to remain cautious.

RTTNews | 1h 28min atrás

FTSE Up Nearly 0.6%; Miners Among Top Gainers

The U.K. market remains well placed in positive territory in early afternoon trades on Wednesday, coming back strongly after posting a notable loss in the previous session. Mining stocks are among the prominent gainers.

RTTNews | 2h 16min atrás

CAC 40 Up Nearly 1%; Schneider Electric Rises Over 3.5%

French stocks are up firmly in positive territory on Wednesday, recovering strongly after suffering a setback in the previous session amid concerns over debt sustainability in major economies across Europe and Asia, and political uncertainty in France.

RTTNews | 2h 54min atrás